Disclaimer: The Views/Opinions expressed and/or opinions provided in Videos and other content on MedEnrich Website are those of respective speakers. They do not purport to reflect the opinion or views of Dr.Reddy’s Laboratories Limited or its affiliates (collectively Dr.Reddy’s)in any manner whatsoever and accordingly ,Dr.Reddys does not recommend , endorse or make any representation about the veracity and appropriateness of the views ,opinions/ information on MedEnrich website. Content on MedEnrich website may discuss uses and dosage for therapeutic product that may not have been approved in by the relevant regulatory agencies in your country. Dr.Reddy’s does not support , endorse or encourage any off-label use. Please refer to approved label before prescribing.
Video Player is loading.
Duration of trastuzumab in patients with Her2 positive Metastatic Breast Cancer in prolonged remission
Breast Cancer Published 2 years ago
Content
Breast Cancer
13m 48s
Improving outcomes in patients with Brain Metastases of Breast Cancer
Published 11 Jul 2022
Prevalence of CNS metastases is increasing because of: better systemic therapies but with limited CNS penetration, better MRI techniques, screening MRI in clinical trials & improved survival of patients with Metastatic Breast Cancer.
